Posts Tagged ‘ SUI ’

Day Two: Batiste v. Ethicon

Mar 19th, 2014 | By
Day Two: Batiste v. Ethicon

Aaron Horton has spend her second day in the Dallas Courtroom where Linda Batiste is attempting to hold Ethicon, a division of Johnson & Johnson, accountable for her mesh-related injuries. In 2011 she was implanted with the incontinence mesh TVT-O and today she continues to suffer the complications.  Horton, whose mother is mesh-injured (see background
[continue reading...]



Texas Transvaginal Mesh Trial Alleges Defective Ethicon TVT-O

Mar 18th, 2014 | By
Texas Transvaginal Mesh Trial Alleges Defective Ethicon TVT-O

Linda Batiste v John Robert McNabb M.D. and Ethicon Inc., and Johnson & Johnson. Jury selection was completed Monday, March 17,  in a Dallas courtroom in the case of Linda Batiste v. Ethicon, Johnson & Johnson (13-cv-04800). This will be the second case that goes to trial in a state court. The case of Linda
[continue reading...]



Endo/ American Medical Systems Under Investigation for Transvaginal Mesh

Mar 5th, 2014 | By
Endo/ American Medical Systems Under Investigation for Transvaginal Mesh

Endo Health Solutions took over American Medical Systems (AMS) in 2011 for $2.9 billion and in doing do inherited roughly 22,000 transvaginal mesh lawsuits. That may have been a mistake. In its annual report released by the Securities and Exchange Commission Monday, Endo says it has received subpoenas from several states investigating its pelvic mesh
[continue reading...]



Endo/American Medical System Sets Aside $520 Million for Mesh Litigation Costs

Feb 26th, 2014 | By

Whether you settle a lawsuit or fight it to the bitter end, it costs a lot to be involved in transvaginal mesh litigation. Endo Health Solutions, the parent company of American Medical Systems (AMS) has set aside approximately $520 million to cover those costs according to its Securities and Exchange Commission filing (SEC) just released
[continue reading...]



Slater’s Trial Schedule for Ethicon Transvaginal Mesh Cases

Jan 30th, 2014 | By
Slater’s Trial Schedule for Ethicon Transvaginal Mesh Cases

Adam Slater is the attorney who took the Linda Gross case to trial last February where he secured the largest jury award yet granted to a mesh-injured woman $11.1 million. Of that award $7.76 million was punitive, intended to punish Johnson & Johnson for its action. Background story here. While that case remains on appeal
[continue reading...]



American Urogyn Society: Mesh Slings Are Safe – Blame Lawyers and Media for Controversy

Jan 14th, 2014 | By
American Urogyn Society: Mesh Slings Are Safe – Blame Lawyers and Media for Controversy

The jury has been out on the safety of slings to treat stress urinary incontinence (SUI). When the Food and Drug Administration issued its warning to the public in July 2011 (here) it said essentially that the much larger transvaginal mesh used to treat pelvic organ prolapse (POP) carried more risk than benefits and that
[continue reading...]



MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

Dec 19th, 2013 | By
MND Interviews Dr. Veronikis: On Transvaginal Mesh, Injuries and Explants

The name of Dr. Dionysios Veronikis St. Louis is one that is increasingly heard among mesh-injured women.  Dr. Veronikis tells Mesh News Desk (MND) he now spends half of his time doing mesh removal surgeries, also known as explants, and although he still uses synthetic mesh on rare occasions, his surgical skills allow him to
[continue reading...]



FDA Approves New American Medical System Transvaginal Mesh Sling

Dec 9th, 2013 | By
FDA Approves New American Medical System Transvaginal Mesh Sling

American Medical Systems (AMS) has just received FDA clearance to market a new incontinence sling, according to a press release that appears in the Wall Street Journal. The RetroArc Retropubic Sling System received the Food the Drug Administration’s 510(k) clearance, a standard that does not require any clinical trials but relies on naming a similar 
[continue reading...]



SUBROGATION & MESH– What it means and why you must understand it

Oct 30th, 2013 | By
SUBROGATION & MESH– What it means and why you must understand it

By Aaron Leigh Horton According Dr. Shlomo Raz at UCLA, the leading expert for 100% removal of transvaginal mesh from the body, “I think that more than 1 million patients [have polypropylene mesh implanted]! The companies have reported insertion of 250,000 implants per year!  This number is an estimate of the worldwide use of mesh.”
[continue reading...]



The Faces of Mesh – One Woman’s Baffling Battle

Oct 16th, 2013 | By
The Faces of Mesh – One Woman’s Baffling Battle

The Faces of Mesh – One Woman’s Baffling Battle October 4, 2013 By Aaron Leigh Horton *Editors Note- Vance is at UCLA at this writing and planning surgery with Dr. Raz on Friday, October 18,2013! Navigating through a violent Texas rainstorm in August was not how I pictured the moments leading up to my very
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.